India pharma giants and global big pharma join forces for NMEs commercialisation in India: GlobalData Read more
India’s fight against rare diseases needs more focus on awareness and diagnosis: GlobalData Read more
Sugemalimab approval in China makes it only second drug approved globally for ENKTL: GlobalData Read more
ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle: GlobalData Read more
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData Read more
Long road ahead for non-statin therapies in Australia dyslipidemia treatment space: GlobalData Read more